GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

StemGen SGNI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.10

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

StemGen — daily SGNI Delayed
Market value
$4.6m
Last close × shares
Volume
3
Shares, 30 Oct 2026

About StemGen

Its shares trade under the ticker SGNI. It has been listed since 11 January 2008. In the fiscal year to 30 June 2021, it reported revenue of $39,000 and a net loss of $433,000. At that date it held total assets of $401,643 and shareholders' equity of −$1.3m.

StemGen, Inc. engages in the acquisition of a company with a well developed business plan to participate in an emerging industry. The company is headquartered in Angleton, Texas. The company went IPO on 2008-01-11. The firm searches for targets that have a market-ready product or process that requires additional assistance to move ahead in their market. The firm holds 100% of the membership interests in Global Visionary Investments LLC (Global Visionary), which is a business advisory services company. Global Visionary has a license with SOKAP, which provides business intelligence in deal sourcing and target vetting. Through their geo-targeting software platform, the acquisition targets have the opportunity to market their products and services in a different way through licensing specific territories for the sale of their products or services.

Figures and description from our data supplier, not checked against the company's own report.

More about StemGen →

Latest on StemGen

Our reporting

We have not reported on StemGen yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is StemGen's ticker?

StemGen trades as SGNI on its US listing, under ISIN US85858B1098.

What was StemGen's last closing price?

0.10 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.